Insights

Gathering insights about xMedica…

Similar companies to xMedica

xMedica Tech Stack

xMedica uses 8 technology products and services including Facebook Pixel, BootstrapCDN, cdnjs, and more. Explore xMedica's tech stack below.

Facebook Pixel
Analytics
BootstrapCDN
Content Delivery Network
cdnjs
Content Delivery Network
Video.js
Javascript Libraries
Google Tag Manager
Tag Management
Google Analytics
Web Analytics
Apache HTTP Server
Web Servers
Facebook
Widgets

Media & News

Analyzing PaxMedica (NASDAQ:PXMD) and Leap Therapeutics (NASDAQ:LPTX)
Leap Therapeutics (NASDAQ: LPTX - Get Free Report) and PaxMedica (NASDAQ: PXMD - Get Free Report) are both small-cap manufacturing companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk. Insider and Institutional Ownership 30.5% of Leap Therapeutics
Dec 18, 2025 | www.defenseworld.net
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions
BOSTON, MA / ACCESSWIRE / January 14, 2025 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing treatments for neurological disorders, is pleased to announce it has received a Notification to Grant Patent Right for Chinese Invention Patent Application No: 2020800553323, Compositions and methods for treating cognitive, social, or behavioral disabilities and neurodevelopmental disorders, such as those found in individuals impacted by autism. Howard Weisman, CEO of PaxMedica commented, "This is an extraordinary milestone for PaxMedica, as this is the first jurisdiction in the world where intellectual property protection of any form of suramin has been approved, since it was first used in humans over 100 years ago.
Jan 14, 2025 | www.accesswire.com
PaxMedica Secures Immediate Exercise of Warrants
TARRYTOWN, NY / ACCESSWIRE / September 3, 2024 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing treatments for neurological disorders, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 4,423,080 shares of common stock of the originally issued in November 2023, having an exercise price of 1.30 per share, at a reduced exercise price of $0.20 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No.
Sep 03, 2024 | www.accesswire.com
PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection
Company provides update on regulatory progress towards US NDA submission TARRYTOWN, NY / ACCESSWIRE / August 27, 2024 / PaxMedica, Inc. (OTC PINK:PXMD), a clinical-stage biopharmaceutical company dedicated to advancing treatments for neurological disorders, is pleased to announce a significant milestone in its global health efforts. The Malawi Ministry of Health has informed the company that a patient suffering from the potentially fatal parasitic infection known as Human Africa Trypanosomiasis Brucei Rhodesiense, (HAT), commonly referred to as African Sleeping Sickness, has recently received treatment with PAX-101, an intravenous form of Suramin, and is recovering at home.
Aug 27, 2024 | www.accesswire.com
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
TARRYTOWN, New York, May 15, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (the “Company” or “PaxMedica”) ( OTC:PXMD ), a biopharmaceutical company dedicated to advancing treatments for neurological disorders, today announced it has timely filed a formal notice of appeal with the Nasdaq Office of Appeals and Review to reverse the decision of a Nasdaq Hearings Panel to delist the Company from Nasdaq. Following receipt of notification from Nasdaq on April 30th, PaxMedica determined to appeal the decision and intends to maintain that the Hearings Panel did not consider sufficiently or appropriately crucial aspects of PaxMedica's recent achievements and ongoing actions to regain compliance with all applicable requirements for continued listing. PaxMedica has retained Jacob Frenkel, Dickinson Wright, PLLC as its lead counsel in the appeal, working with the consulting firm that interacted previously with the Hearings Panel.
May 15, 2024 | www.globenewswire.com
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
TARRYTOWN, New York, April 23, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica Inc. (Nasdaq: PXMD) (the “Company”), a leading biopharmaceutical company dedicated to advancing treatments for neurological disorders, expects to take immediate action in response to an urgent request for IV suramin from the Ministry of Health (MOH) of Malawi, a country in east Africa. The request seeks emergency access to the Company's recently completed registration batches of PAX-101 (IV suramin) to address the critical shortage of medications required to combat the life-threatening sleeping sickness, also known as Trypanosoma brucei rhodesiense, Human African trypanosomiasis (TBr HAT), crisis in the region.
Apr 23, 2024 | www.globenewswire.com
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
TARRYTOWN, New York, April 16, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica , Inc. (NASDAQ: PXMD ), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced it has received an urgent request from the Ministry of Health (MOH) of Malawi, asking for emergency access to IV suramin to avert a potential humanitarian crisis brought on by dwindling supplies of drugs used routinely to save lives in that region of Africa.
Apr 16, 2024 | www.globenewswire.com

xMedica's Email Address Formats

xMedica uses at least 1 format(s):

xMedica Email Formats	Example	Percentage
First@x-medica.com	John@x-medica.com	50%
First@x-medica.com	John@x-medica.com	50%

Frequently Asked Questions

Where is xMedica's headquarters located?

xMedica's main headquarters is located at 10945 State Bridge Road, Suite 401-302 Alpharetta, GA 30022, US. The company has employees across 1 continents, including North America.

What is xMedica's phone number?

You can contact xMedica's main corporate office by phone at

+1-866-477-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is xMedica's stock symbol?

xMedica is a publicly traded company; the company's stock symbol is PXMD.

What is xMedica's official website and social media links?

xMedica's official website is x-medica.com and has social profiles on LinkedIn.

What is xMedica's NAICS code?

xMedica's NAICS code is 5415 - Computer Systems Design and Related Services.

How many employees does xMedica have currently?

As of December 2025, xMedica has approximately 1 employees across 1 continents, including North America. Key team members include President: T. H.Founder & President: B. B. W.Program Manager: L. B.. Explore xMedica's employee directory with LeadIQ.

What industry does xMedica belong to?

xMedica operates in the Technology, Information and Internet industry.

What technology does xMedica use?

xMedica's tech stack includes Facebook PixelBootstrapCDNcdnjsVideo.jsGoogle Tag ManagerGoogle AnalyticsApache HTTP ServerFacebook.

What is xMedica's email format?

xMedica's email format typically follows the pattern of First@x-medica.com. Find more xMedica email formats with LeadIQ.

When was xMedica founded?

xMedica was founded in 2005.

xMedica

Q: What is xMedica's official website and social media links?

xMedica's official website is x-medica.com. xMedica has social profiles on LinkedIn.

Q: How many employees does xMedica have currently?

xMedica has approximately 1 employees.

Q: What technology does xMedica use?

xMedica's tech stack includes BootstrapCDN, jQuery Validation Plugin, Bootstrap, PHP, Facebook Pixel.

Technology, Information and InternetUnited States0-1 Employees

xMedica is an industry leader in developing innovative, continuing education (CME) programs designed to support continuous learning for today's physicians and other healthcare professionals. Our goal is always to provide our users with objective, well-balanced material for a variety of therapeutic categories.

www.x-Medica.com

Company Overview

Headquarters: 10945 State Bridge Road, Suite 401-302 Alpharetta, GA 30022, US
Phone number: +1-866-477-****
Website: x-medica.com
Stock Symbol: PXMD
NAICS Code: 5415 - Computer Systems Design and Related Services
Founded: 2005
Employees: 0-1

Media & News

Funding & Financials

$1M$10M
xMedica's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$1M$10M
xMedica's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to xMedica

BD

Abbott

Johnson & Johnson

Medtronic

Solventum Medical

Stryker

GE HealthCare

Siemens Healthineers

Boston Scientific

xMedica Tech Stack

Media & News

Analyzing PaxMedica (NASDAQ:PXMD) and Leap Therapeutics (NASDAQ:LPTX)

PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions

PaxMedica Secures Immediate Exercise of Warrants

PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection

PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101

PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness

xMedica's Email Address Formats

Frequently Asked Questions

Where is xMedica's headquarters located?

What is xMedica's phone number?

What is xMedica's stock symbol?

What is xMedica's official website and social media links?

What is xMedica's NAICS code?

How many employees does xMedica have currently?

What industry does xMedica belong to?

What technology does xMedica use?

What is xMedica's email format?

When was xMedica founded?

xMedica

Company Overview

Media & News

Analyzing PaxMedica (NASDAQ:PXMD) and Leap Therapeutics (NASDAQ:LPTX)

PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions

PaxMedica Secures Immediate Exercise of Warrants

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?